Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Todos Med Ltd. (TOMDF) Message Board

Isn't it funny how JPeckerHead always comes to min

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 1418
(Total Views: 279)
Posted On: 06/17/2022 6:35:18 PM
Avatar
Posted By: Warp
Re: redspeed #1085
Isn't it funny how JPeckerHead always comes to mind when someone mentions the words fucking moron or idiot or loser?

Why do people have that perception?

Interesting tidbits about JPeckerHead's beloved IBIO investment.

IBIO conducted a 1-to-10 reverse split on June 11,2018.

IBIO is now seeking a 1-to-25 reverse split approval from shareholders in 2022.

According to OTC, IBIO has 218,165,624 shares issued as of 5/9/22.

If we compare to TOMDF on a pre-split basis because Todos has yet to perform a reverse split, IBIO has effectively issued twice as many shares as Todos, and is now having to resort to yet another reverse split because of declining share price. That's two RS for that reason. Sad how some pump this stock as it continues to decline and take drastic measures instead of addressing their declining revenues.

TOMDF: 1,193,175,121 shares issued - no splits

IBIO: 2,181,656,240 shares issued - split adjusted

Todos has increasing revenues, and is only discussing a reverse split in regards to Nasdaq uplist from a position of strength when share price supports based on business growth and 3CL Pharma spinoff transaction, not as a stop-gap measure to save a sinking ship.

But JPeckerhead trashes Todos share structure and dilution while iBio has been effectively twice as bad, and he pumps that one. Come to think of it, when someone says the word hypocrite, JPeckerhead also comes to mind. LMAO

The questions I want answered:

1. How many pics of Gerald Commissiong does JPeckerHead have in his collection?

2. Does he fantasize about Gerald while masturbating or having sex with his wife?

3. Can he still even get it up without thinking of Gerald?


(2)
(0)




Todos Med Ltd. (TOMDF) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us